In addition, studies in breast cancer showed that endostatin p.D104N is associated with invasive breast cancer15, and patients carrying this polymorphism exhibited shorter progression-free survival and overall survival compared to those with wild type endostatin22. Here, COL18A1 is linked to breast cancer.